BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22689714)

  • 1. Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK.
    Collins GS; Altman DG
    Heart; 2012 Jul; 98(14):1091-7. PubMed ID: 22689714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualising the risks of statins in men and women in England and Wales: population-based cohort study.
    Hippisley-Cox J; Coupland C
    Heart; 2010 Jun; 96(12):939-47. PubMed ID: 20489220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database.
    Hippisley-Cox J; Coupland C
    BMJ; 2010 May; 340():c2197. PubMed ID: 20488911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.
    García Rodríguez LA; Herings R; Johansson S
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1218-24. PubMed ID: 20922707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of statin use with cataracts: a propensity score-matched analysis.
    Leuschen J; Mortensen EM; Frei CR; Mansi EA; Panday V; Mansi I
    JAMA Ophthalmol; 2013 Nov; 131(11):1427-34. PubMed ID: 24052188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.
    Collins GS; Altman DG
    Cancer Epidemiol; 2013 Apr; 37(2):115-20. PubMed ID: 23280341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.
    García-Rodríguez LA; Massó-González EL; Wallander MA; Johansson S
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):943-52. PubMed ID: 18425988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Use and Incident Cataract Surgery: A Case-Control Study.
    Erie JC; Pueringer MR; Brue SM; Chamberlain AM; Hodge DO
    Ophthalmic Epidemiol; 2016; 23(1):40-5. PubMed ID: 26766069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study.
    Mansi IA; English J; Zhang S; Mortensen EM; Halm EA
    Drug Saf; 2016 Jun; 39(6):543-59. PubMed ID: 26979831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and incident nuclear cataract.
    Klein BE; Klein R; Lee KE; Grady LM
    JAMA; 2006 Jun; 295(23):2752-8. PubMed ID: 16788130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
    Goettsch WG; Heintjes EM; Kastelein JJ; Rabelink TJ; Johansson S; Herings RM
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):435-43. PubMed ID: 16761304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use and risk for cataract: a nested case-control study of 2 populations in Canada and the United States.
    Wise SJ; Nathoo NA; Etminan M; Mikelberg FS; Mancini GB
    Can J Cardiol; 2014 Dec; 30(12):1613-9. PubMed ID: 25475465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.
    Bangalore S; Fayyad R; Hovingh GK; Laskey R; Vogt L; DeMicco DA; Waters DD;
    Am J Cardiol; 2014 Jun; 113(12):2018-20. PubMed ID: 24793673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 15. External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes.
    Collins GS; Altman DG
    Diabet Med; 2011 May; 28(5):599-607. PubMed ID: 21480970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.
    Chang CH; Chang YC; Lee YC; Liu YC; Chuang LM; Lin JW
    J Gastroenterol Hepatol; 2015 Jan; 30(1):155-62. PubMed ID: 25041076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent statin use and cataract surgery.
    Fong DS; Poon KY
    Am J Ophthalmol; 2012 Feb; 153(2):222-228.e1. PubMed ID: 21982100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney® scores using a primary care database.
    Collins G; Altman D
    Br J Gen Pract; 2012 Apr; 62(597):e243-50. PubMed ID: 22520911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
    Collins GS; Mallett S; Altman DG
    BMJ; 2011 Jun; 342():d3651. PubMed ID: 21697214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.